Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Shiqun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3504-1473; OpenAlex author ID A5016532942. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. Co-author DOI 10.1073/pnas.2535905123↗
  2. IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1038/s41467-025-65762-4↗
  3. Expanding the ubiquitin code in pancreatic cancer. First author DOI 10.1016/j.bbadis.2023.166884↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiang‐Jiang Qin · 3 shared papers, 2024–2026 · strength 0.77
  2. Wenyan Yang · 2 shared papers, 2024–2025 · strength 0.51
  3. Weidong Zhang · 2 shared papers, 2025–2026 · strength 0.49
  4. Xin Luan · 2 shared papers, 2025–2026 · strength 0.49
  5. Weidong Zhang · 1 shared paper, 2024 · strength 0.28
  6. Yiwen Shen · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.